Clinical Trial Update: ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating ZR2 followed by immunochemotherapy in elderly patients with newly diagnosed diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• ZR2

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN